Metraipolis › archive › dc_ebe4bceebee8

Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model — Europe PMC PMID:42350385

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42350385
DOI: 10.1038/s41467-[numero omesso]-8
License (as archived): solo-consultazione
Archived: 2026-10-19T00:26:38.305Z
SHA-256 of the archived text: 3283406735a4235ff82af0db90711cad7cbf1dc227b6d7cf81ac8ae0701b178e
Stable URL of this page: https://metraipolis.com/documento/dc_ebe4bceebee8

How to cite

Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model — Europe PMC PMID:42350385 — Europe PMC (en), https://europepmc.org/article/MED/42350385 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebe4bceebee8 (Metraipolis archive dc_ebe4bceebee8, sha256 3283406735a4235ff82af0db90711cad7cbf1dc227b6d7cf81ac8ae0701b178e)

BibTeX

@misc{dcebe4bceebee8,
  title = {Intravenous administration of an engineered AAV9-gene-silencing vector suppresses human SOD1 and extends survival in an ALS mouse model — Europe PMC PMID:42350385},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42350385},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebe4bceebee8; sha256 3283406735a4235ff82af0db90711cad7cbf1dc227b6d7cf81ac8ae0701b178e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42350385. Agents can read the archived copy with the MCP tool read_document.